WEBULL
WebtradeDownload

Edenred (ENXTPA:EDEN) Brings In Abry Partners, Is The Stock Fully Valued?

Simply Wall St · 1d ago

Edenred (ENXTPA:EDEN) has drawn fresh attention after agreeing to bring Abry Partners into Edenred Pay North America through a €75 million equivalent cash investment and a structure that gives Abry exposure to future equity value.

See our latest analysis for Edenred.

The Edenred share price has climbed sharply in recent months, with a 30 day share price return of 22.46% and a 90 day gain of 36.51%. The year to date share price return of 53.85% contrasts with a weaker 3 year total shareholder return that declined 44.37%, suggesting recent momentum has returned even as the longer term record remains under pressure.

If this kind of corporate deal has your attention, it could be a good time to widen your watchlist and use our screener to uncover 108 top founder-led companies

Edenred now trades only slightly below the median analyst target, yet appears to sit at a steep discount to one intrinsic value estimate. After this sharp re rating, is the market still too cautious or already rightly sceptical?

Most Popular Narrative: 1% Overvalued

Edenred closed at €28.90, slightly above the narrative fair value of €28.53, which frames the current debate around recent share price strength.

Persistent operating leverage from the company's digital platform and execution of efficiency programs (like Fit for Growth) are driving operating expense growth below revenue growth, resulting in widening margins and improving free cash flow conversion, which together underpin sustainable earnings growth.

Read the complete narrative. Read the complete narrative.

To understand why a modest premium looks acceptable to this narrative, the focus is on steady revenue expansion, firm margins and a tighter share count. This raises the question of which specific earnings path and profit multiple sit behind that €28.53 figure.

Result: Fair Value of €28.53 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Edenred's story could change quickly if European demand slows further or if tighter regulation and rising fintech competition squeeze pricing and margins.

Find out about the key risks to this Edenred narrative.

Another View on Edenred's Valuation

The first narrative suggests Edenred is only slightly overvalued around the €28.53 mark. The P/E based view tells a different story. Edenred trades on a 13.3x P/E, while the fair ratio is 17.4x and the European Diversified Financial industry sits nearer 11.3x. That mix of discount to fair ratio but premium to peers raises a simple question for investors: Is this a quality premium or a margin of safety mirage?

To see how this ratio based view is built, and what would need to change for the market to move closer to the fair ratio, See what the numbers say about this price — find out in our valuation breakdown.

ENXTPA:EDEN P/E Ratio as at Aug 2026
ENXTPA:EDEN P/E Ratio as at Aug 2026

Next Steps

If this mix of fresh optimism and lingering concerns around Edenred leaves you on the fence, take a closer look at both sides before you decide where you stand. Start by weighing the 2 key rewards and 3 important warning signs

Looking for more investment ideas beyond Edenred?

If Edenred has sharpened your focus, do not stop here. Broaden your watchlist now and give yourself more options before the next big move passes you by.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.